Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 17Gastrointestinal 8Thoracic 5Head & Neck 5Tumor-Agnostic 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Genitourinary 2Other 1CNS 1

Conditions

Supratentorial Neoplasms 1Epilepsy 1Brain Neoplasms 1Arteriovenous Malformations 1Aneurysm 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bupivacaine × CNS × Clear all
NCT00972790 2012-03-01

Scalp Nerve Blocks for Post-Craniotomy Pain

Unity Health Toronto

Phase NA Completed
89 enrolled
CNS

Aneurysm, Arteriovenous Malformations, Brain Neoplasms, Epilepsy, Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡